Modern Biotechnology and India’s Governance Imperatives

By Ananth Padmanabhan, R. Shashank Reddy, and Shruti Sharma
Carnegie Endowment for International Peace
1 October 2017

Advances in the biotech sector are geared to transform existing ethical assumptions, while unravelling a host of products and services that can benefit humankind. The tradeoffs involved across various sub-verticals, including biodiversity exploration, gene editing, and genetically modified food substances, require a scientifically well-equipped regulator to discharge its responsibilities without undue political interferences. This paper argues that these background conditions do not presently exist in India, and recommends policy pathways going ahead.